Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest
Beginning Balance at Dec. 31, 2020	[1]	$ 30,611	$ 164	$ 417,855	$ (387,408)	$ 0
Beginning Balance, Shares at Dec. 31, 2020	[1]		164,063,787
Net loss attributable to Alignment Healthcare, Inc.		(101,636)	$ 0	0	(101,636)	0
Noncontrolling interest attributable to subsidiary		15	0	0	0	15
Issuance of common stock, net of issuance costs		361,589	$ 22	361,567	0	0
Issuance of common stock, net of issuance costs, Shares			21,700,000
Issuance of common stock to third-party business partners		6,480	$ 1	6,479	0	0
Issuance of common stock to third-party business partners, Shares			573,782
Issuance of common stock to stock appreication rights holders		11,510	$ 1	11,509	0	0
Issuance of common stock to stock appreication rights holders, Shares			936,213
Equity-based compensation		33,285	$ 0	33,285	0	0
Equity repurchase		(1,474)	0	(1,474)	0	0
Ending Balance at Jun. 30, 2021		340,380	$ 188	829,221	(489,044)	15
Ending Balance, Shares at Jun. 30, 2021			187,273,782
Beginning Balance at Mar. 31, 2021		354,252	$ 188	798,346	(444,282)	0
Beginning Balance, Shares at Mar. 31, 2021			187,273,782
Net loss attributable to Alignment Healthcare, Inc.		(44,762)	$ 0	0	(44,762)	0
Noncontrolling interest attributable to subsidiary		15	0	0	0	15
Common stock issuance costs		(12)	0	(12)	0	0
Equity-based compensation		30,887	0	30,887	0	0
Ending Balance at Jun. 30, 2021		340,380	$ 188	829,221	(489,044)	15
Ending Balance, Shares at Jun. 30, 2021			187,273,782
Beginning Balance at Dec. 31, 2021		$ 306,055	$ 187	888,547	(582,694)	15
Beginning Balance, Shares at Dec. 31, 2021		187,193,613	187,193,613
Net loss attributable to Alignment Healthcare, Inc.		$ (52,397)	$ 0	0	(52,397)	0
Issuance of common stock upon vesting of restricted stock units			432,484
Forfeitures		0	$ 0	0	0	0
Forfeitures, shares			(354,786)
Equity-based compensation		40,146	$ 0	40,146	0	0
Repurchase of noncontrolling interest attributable to subsidiary		(100)	0	(85)	0	(15)
Ending Balance at Jun. 30, 2022		$ 293,704	$ 187	928,608	(635,091)	0
Ending Balance, Shares at Jun. 30, 2022		187,271,311	187,271,311
Beginning Balance at Mar. 31, 2022		$ 293,285	$ 187	916,594	(623,511)	15
Beginning Balance, Shares at Mar. 31, 2022			187,414,057
Net loss attributable to Alignment Healthcare, Inc.		(11,580)	$ 0	0	(11,580)	0
Issuance of common stock upon vesting of restricted stock units			48,976
Forfeitures		0	$ 0	0	0	0
Forfeitures, shares			(191,722)
Equity-based compensation		12,099	$ 0	12,099	0	0
Repurchase of noncontrolling interest attributable to subsidiary		(100)		(85)		(15)
Ending Balance at Jun. 30, 2022		$ 293,704	$ 187	$ 928,608	$ (635,091)	$ 0
Ending Balance, Shares at Jun. 30, 2022		187,271,311	187,271,311

[1] The consolidated balances as of December 31, 2020 were derived from the audited consolidated financial statements as of that date and were retroactively adjusted, including shares and per share amounts, as a result of the Reorganization. See Note 1 to the condensed consolidated financial statements for additional details.